$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Solid dose delivery vehicle and methods of making same 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/50
출원번호 US-0349029 (1994-12-02)
발명자 / 주소
  • Roser Bruce J.,GBX
  • Kampinga Jaap,NLX
  • Colaco Camilo,GBX
  • Blair Julian,GBX
출원인 / 주소
  • Quandrant Holdings Cambridge Limited, GBX
대리인 / 주소
    Saliwanchik, Lloyd & Saliwanchik
인용정보 피인용 횟수 : 127  인용 특허 : 41

초록

The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass lo

대표청구항

[ What is claimed is:] [20.]20. The composition, according to claim 17, wherein said hormone is selected from the group consisting of peptides, steroids and corticosteroids.

이 특허에 인용된 특허 (41)

  1. Nishikawa Yoshihiro (Kanazawa JPX) Kanemitsu Kimihiro (Kanazawa JPX) Katori Tatsuhiko (Ibaragi JPX) Shibata Akihiro (Narashino JPX) Kukita Kenichi (Kashiwa JPX), aa 상세보기
  • Kwan Henry K. H. (Summit NJ), Biologically stable interferon compositions comprising thimerosal.
  • Puglia Wayne J. (Bellerose Village NY) Patanasinth Kanit J. (Tarrytown NY) Lombardo Andrew T. (Bronx NY) Beam John E. (Norwalk CT) Mackay Donald A. M. (Pleasantville NY), Compressed chewable antacid tablet and method for forming same.
  • Puglia Wayne J. (Bellerose Village NY) Patanasinth Kanit J. (Tarrytown NY) Lombardo Andrew T. (Bronx NY) Vink Walter (Purdys Station NY), Compressed chewable antacid tablet and method for forming same.
  • Portenhauser Rudolf (Tutzing DEX) Bartl Knut (Wilzhofen DEX), Control or calibration serum for lipid diagnosis.
  • Drake Cyril F. (Harlow GB2) Arch Alfred J. (Ongar GB2), Controlled delivery device.
  • Drake Cyril F. (Harlow GBX), Controlled delivery devices.
  • Mitsuhashi Masakazu (Okayama JPX) Sakai Shuzo (Okayama JPX) Miyake Toshio (Okayama JPX), Dehydration of hydrous matter using anhydrous glycosylfructose.
  • Myers Garry L. (Reston VA) Battist Gerald E. (Reston VA) Fuisz Richard C. (Great Falls VA), Delivery of controlled-release systems(s).
  • Shibata Akihiro (Narashino JPX) Matsuda Hideaki (Abiko JPX) Kohya Hidehiko (Sendai JPX) Katori Tatsuhiko (Tone JPX), Derivative of aa 상세보기
  • Neurath A. Robert (New York NY), Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide.
  • Shishov Nikolai M. (Moscow SUX) Zelenetsky Vladimir E. (Moscow SUX) Demina Nadezhda A. (Moscow SUX) Bondarev Ivan M. (Moscow SUX) Cherny Alexandr N. (Moscow SUX) Moskvitin Valery A. (Belgorod-Dnestro, Device for administering powdered substances.
  • Bonderman Ruby P. (Noblesville IN), Diagnostic and therapeutic compositions.
  • Gibson Timothy D. (Leeds OH GB2) Woodward John R. (Xenia OH), Enzyme stabilisation.
  • Cleland Jeffrey L. (San Carlos CA) Jones Andrew J. S. (San Mateo CA), Excipient stabilization of polypeptides treated with organic solvents.
  • Drake Cyril F. (Harlow GB2) Tripp Mary (Bishop\s Stortford GB2), Glass composition.
  • Samuels W. D. (Richland WA) Exarhos Gregory J. (Richland WA), Glass/polymer composites and methods of making.
  • Ducheyne Paul (Rosemont PA) Radin Shulamith (Voorhees NJ) Santos Erick M. (Philadelphia PA), Incorporation of biologically active molecules into bioactive glasses.
  • Livesey Stephen A. (The Woodlands TX) Linner John G. (The Woodlands TX), Method for cryopreparing biological tissue.
  • McHugh John E. (11633 S. Hawthorne Blvd. Hawthorne CA 90250), Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide.
  • Hastings Donald H. (Bismarck ND), Method of producing antibody-fortified dry whey.
  • Wettlaufer Scott H. (Newfield NY) Leopold Aldo C. (Ithaca NY), Method of protecting biological materials from destructive reactions in the dry state.
  • Goodrich ; Jr. Raymond P. (Pasadena CA) Williams Christine M. (Pasadena CA), Method of reconstituting lyophilized cells.
  • Patton John S. ; Foster Linda ; Platz Robert M., Methods and compositions for pulmonary delivery of insulin.
  • Radhakrishnan Ramachandran (Fremont CA), Novel liposome composition for the treatment of interstitial lung diseases.
  • Zema Marco (Como ITX) Mapelli Luigi G. (Milan ITX) Marconi Marco G. (Milan ITX), Pharmaceutical composition for rapid suspension in water.
  • Johnson Eric A. (Madison WI) Goodnough Michael C. (Madison WI), Pharmaceutical composition of botulinum neurotoxin and method of preparation.
  • Suzuki Yoshiki (Tokyo JPX) Sekine Kunio (Tokyo JPX) Nagai Tsuneji (Tokyo JPX) Nambu Naoki (Kanagawa JPX) Nishimoto Yuji (Tokyo JPX), Powdery pharmaceutical composition for nasal administration.
  • Bogue B. Arlie (Broad Run VA) Fuisz Richard C. (Great Falls VA) Hiscocks Peter G. (Saffron Walden GB2), Process for making shearform matrix.
  • Louderback Allan L. (Temple City CA), Process for preparing a biological composition for use as a reference control in diagnostic analysis.
  • Platz Robert M. (Half Moon Bay CA) Ip Anna (Moorpark CA) Whitham Clyde L. (Montara CA), Process for preparing micronized polypeptide drugs.
  • Pitt Colin G. (Thousand Oaks CA) Platz Robert M. (Half Moon Bay CA), Pulmonary administration of erythropoietin.
  • Platz Robert M. (Half Moon Bay CA) Winters Mark A. (Mountain View CA) Pitt Colin G. (Thousand Oaks CA), Pulmonary administration of granulocyte colony stimulating factor.
  • Fuisz Richard C. (Bethlehem PA), Rapidly dissoluble medicinal dosage unit and method of manufacture.
  • Fuisz Richard C. (Great Falls VA), Saccharide-based matrix.
  • Hoskins Michael K. (Irvine CA), Stabilized isoenzyme control products.
  • Li Mutti ; Charles M. ; Wu ; Tai-Wing ; Lynn ; Shirley Y., Stabilizers for reconstituted, lyophilized samples.
  • Franks Felix (Cambridge GB2) Hatley Ross H. M. (Hardwick GB2), Storage of materials.
  • Tai Anna W. (Bridgewater NJ), Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same.
  • Illum Lisbeth (The Park GBX), Transmucosal formulations of low molecular weight peptide drugs.
  • Koyama Shunsaku (Okayama JPX) Miyake Toshio (Okayama JPX), Water-soluble dry solid containing proteinaceous bioactive substance.
  • 이 특허를 인용한 특허 (127)

    1. Glenn,Gregory M.; Alving,Carl R., Adjuvant for transcutaneous immunization.
    2. Garidel, Patrick; Henderson, Isaac Craig; Klein, Pamela, Antibody formulations and methods.
    3. Garidel, Patrick; Henderson, Isaac Craig; Klein, Pamela, Antibody formulations and methods for treating AL amyloidosis.
    4. Tobinaga, Yoshikazu; Sugiyama, Susumu, Applicator for applying functional substances into human skin.
    5. Tian, Bin; Davidson, Jim, Biological tissue for surgical implantation.
    6. Dove, Jeffrey S.; Dobler, Darin P.; Davidson, James A.; Wright, Gregory A., Bioprosthetic tissue with reduced calcification.
    7. Dove, Jeffery; Dobler, Darin; Davidson, Jim; Wright, Gregory, Capping bioprosthetic tissue to reduce calcification.
    8. Dove, Jeffery; Dobler, Darin; Davidson, Jim; Wright, Gregory A., Capping bioprosthetic tissue to reduce calcification.
    9. Dove, Jeffrey S.; Dobler, Darin P.; Davidson, James A.; Wright, Gregory A., Capping bioprosthetic tissue to reduce calcification.
    10. Dove, Jeffrey S.; Dobler, Darin P.; Davidson, James A.; Wright, Gregory A., Capping bioprosthetic tissue to reduce calcification.
    11. Roser, Bruce Joseph; Garcia De Castro, Arcadio, Composition and method for controlled release injections.
    12. Prestrelski, Steven J., Compositions for rapidly treating severe hypoglycemia.
    13. Hanna, Mazen H.; York, Peter, Compositions of particulate coformulation.
    14. First, Eric R., Cosmetic neurotoxin compositions and methods.
    15. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakis, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
    16. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakls, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
    17. Harel, Mordechi, Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same.
    18. Harel, Mordechi; Kohavi-Beck, Keren, Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same.
    19. Harel, Mordechi; Kohavi-Beck, Keren, Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same.
    20. Davidson,Iain; Blair,Julian, Derivatised carbohydrates and their use in solid delivery systems.
    21. Carpentier, Sophie M.; Carpentier, Alain F., Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability.
    22. Harel, Moti; Bennett, Alicia, Dry food product containing live probiotic.
    23. Harel, Moti; Bennett, Alicia, Dry food product containing live probiotic.
    24. Harel, Moti; Bennett, Alicia, Dry food product containing live probiotic.
    25. Harel, Moti; Drewes, Roger; Scarbrough, January, Dry glassy composition comprising a bioactive material.
    26. Buch-Rasmussen, Thomas; Flink, James M.; Poulsen, Jens Ulrich; Aasmul, Søren; Hansen, Philip; Mortensen, Claus Juul, Dry mouldable drug formulation.
    27. Buch-Rasmussen, Thomas; Flink, James M.; Poulsen, Jens Ulrich; Aasmul, Søren; Hansen, Philip; Mortensen, Claus Juul, Dry mouldable drug formulation.
    28. Whitfield, Nicola; Koopman, Jaap; Grimbergen, Jos, Dry powder fibrin sealant.
    29. Harel, Moti; Tang, Qiong, Dry storage stabilizing composition for biological materials.
    30. Ahmad, Ateeq; Ali, Shoukath M.; Ahmad, Moghis U.; Sheikh, Saifuddin; Ahmad, Imran, Endoxifen compositions and methods.
    31. Tarara, Thomas E.; Weers, Jeffry G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Engineered particles and methods of use.
    32. Tarara,Thomas E.; Weers,Jeffry G.; Kabalnov,Alexey; Schutt,Ernest G.; Dellamary,Luis A., Engineered particles and methods of use.
    33. Tarara, Thomas E.; Weers, Jeffry G.; Eldon, Michael A.; Narashimhan, Rangachari; Clark, Andrew, Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use.
    34. Prestrelski, Steven, Formulations for the treatment of diabetes.
    35. Hyde, Roderick A.; Wood, Jr., Lowell L., Glassy compositions.
    36. Coffey, Matthew C.; Serl, Sarah; Pavliv, Leo, Liquid viral formulations.
    37. Coffey, Matthew C.; Serl, Sarah; Pavliv, Leo, Liquid viral formulations.
    38. Coffey, Matthew C.; Serl, Sarah; Pavliv, Leo, Lyophilized viral formulations.
    39. Coffey, Matthew C.; Serl, Sarah; Pavliv, Leo, Lyophilized viral formulations.
    40. Lichtman, Jeff W.; Wong, Wai T.; Wong, Rachel; Gan, Wen-Biao; Grutzendler, Jamie, Method for labeling individual cells.
    41. Smith, Alan; Eppstein, Jonathan A.; Messier, Bernadette; Novakovic, Zoran; McRae, Stuart, Method for transdermal delivery of permeant substances.
    42. Smith, Alan; Eppstein, Jonathan A.; Messier, Bernadette; Novakovic, Zoran; McRae, Stuart, Method for transdermal delivery of permeant substances.
    43. Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih N.; Armer, Thomas A., Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile.
    44. Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih N.; Armer, Thomas A., Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile.
    45. Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih N.; Armer, Thomas A., Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile.
    46. Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih N.; Armer, Thomas A., Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile.
    47. Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih N.; Armer, Thomas A., Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile.
    48. Tian, Bin; Davidson, Jim, Method of treating glutaraldehyde-fixed pericardial tissue with a non-aqueous mixture of glycerol and a C.
    49. Patton, John S.; Foster, Linda S.; Platz, Robert M., Methods and compositions for pulmonary delivery of insulin.
    50. Davidson, Jim; Dove, Jeff; Dobler, Darin, Methods for pre-stressing and capping bioprosthetic tissue.
    51. Prestrelski, Steven; Sandoval, Michael; Donovan, Martin, Methods for producing stable therapeutic formulations in aprotic polar solvents.
    52. Prestrelski, Steven J., Methods for rapidly treating severe hypoglycemia.
    53. Dove, Jeffrey S.; Tod, Tara J., Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates.
    54. Xu, Dengfeng; Dove, Jeffrey S., Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system.
    55. Dove, Jeffrey S.; Tian, Bin; Schneider, Ralph; Cohen, Jeffrey S.; Jankovic, Ivan; Migliazza, John F.; Wright, Gregory A.; Young, James M.; Campbell, Louis A., Methods of conditioning sheet bioprosthetic tissue.
    56. Dove, Jeffrey S.; Tian, Bin; Schneider, Ralph; Cohen, Jeffrey S.; Jankovic, Ivan; Migliazza, John F.; Wright, Gregory A.; Young, James M.; Campbell, Louis A., Methods of conditioning sheet bioprosthetic tissue.
    57. Dove, Jeffrey S.; Tian, Bin; Schneider, Ralph; Cohen, Jeffrey S.; Jankovic, Ivan; Migliazza, John F.; Wright, Gregory A.; Young, James; Campbell, Louis A., Methods of conditioning sheet bioprosthetic tissue.
    58. Dove, Jeffrey S.; Tian, Bin; Schneider, Ralph; Cohen, Jeffrey S.; Jankovic, Ivan; Migliazza, John F.; Wright, Gregory A.; Young, James; Campbell, Louis A., Methods of conditioning sheet bioprosthetic tissue.
    59. Schneider, Ralph; Tian, Bin; Dove, Jeffrey S.; Cohen, Jeff; Jankovic, Ivan; Migliazza, John F.; Wright, Gregory A.; Young, James; Campbell, Louis A., Methods of conditioning sheet bioprosthetic tissue.
    60. Tian, Bin; Schneider, Ralph; Dove, Jeffrey S.; Cohen, Jeff; Jankovic, Ivan; Migliazza, John F.; Wright, Gregory A.; Young, James; Campbell, Louis A., Methods of conditioning sheet bioprosthetic tissue.
    61. Harel, Moti; Carpenter, Brian, Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish.
    62. Eppstein, Jonathan A., Microporation of tissue for delivery of bioactive agents.
    63. Eppstein, Jonathan A., Microporation of tissue for delivery of bioactive agents.
    64. Brown, Larry R.; Giannoukakis, Nick; Gillis, Kimberly A.; Trucco, Massimo, Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes.
    65. Brown, Larry R.; Gillis, Kimberly A.; Gallo, Michael V., Nucleic acid microparticles for pulmonary delivery.
    66. Brown, Larry R.; Scott, Terrence L.; Lafreniere, Debra; Bisker-Leib, Vered, Nucleic acid microspheres, production and delivery thereof.
    67. Scott, Terrence; Lafreniere, Debra; Bisker-Leib, Vered; Brown, Larry, Nucleic acid microspheres, production and delivery thereof.
    68. Lim, Jong Hwan; Hong, Sung-Woon; Ko, Dae Woong; Nam, Seung Kwan; Ahn, Mi Sun; Hwang, Deok-Kyu; Kim, Yeong-Mok; Um, Key-An, Ophthalmic composition comprising cyclosporine and trehalose.
    69. Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, Particulate materials.
    70. Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, Particulate materials.
    71. Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, Particulate materials.
    72. Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, Particulate materials.
    73. Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, Particulate materials.
    74. York, Peter; Shekunov, Boris Yu; Rehman, Mahboob Ur; Feeley, Jane Catherine, Particulate materials.
    75. York, Peter; Shekunov, Boris Yu; Rehman, Mahboob Ur; Feeley, Jane Catherine, Particulate materials.
    76. York, Peter; Shekunov, Boris Yu; Rehman, Mahboob Ur; Feeley, Jane Catherine, Particulate materials.
    77. de Costa, Samodh; Roser, Bruce; Sen, Shevanti, Pharmaceutical device for the administration of substances to patients.
    78. Weers, Jeffry G.; Tarara, Thomas E.; Dellamary, Luis A.; Riess, Jean G.; Schutt, Ernest G., Phospholipid-based powders for drug delivery.
    79. Weers, Jeffry G; Tarara, Thomas E; Dellamary, Luis A; Riess, Jean G; Schutt, Ernest G, Phospholipid-based powders for drug delivery.
    80. Cicerone,Marcus T.; Tellington,Andrew; Trost,Landon; Sokolov,Alexei, Plasticized hydrophilic glasses for improved stabilization of biological agents.
    81. Snyder, Herman E.; Nasiatka, James; Varga, Christopher M., Prefilming atomizer.
    82. Snyder, Herman E; Nasiatka, James; Varga, Christopher M, Prefilming atomizer.
    83. Patton,John S., Pulmonary delivery of active fragments of parathyroid hormone.
    84. Tarara, Thomas E.; Weers, Jeffry G.; Venthoye, Geraldine, Pulmonary delivery of aminoglycoside.
    85. Tarara, Thomas E; Weers, Jeffry G; Venthoye, Maria Geraldine, Pulmonary delivery of aminoglycoside.
    86. Weikert,Michael; Gordon,Marc S.; Kumar,Sandeep; Yang,Bing; Sarwar,Razaq, Pulmonary delivery of polyene antifungal agents.
    87. Tarara, Thomas E.; Weers, Jeffrey G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Pulmonary delivery particles comprising an active agent.
    88. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis A.; Tarara, Thomas E.; Kabalnov, Alexey, Respiratory dispersion for metered dose inhalers comprising perforated microstructures.
    89. Johal, Sarjit; Pollmeier, Albert J., Salt composition.
    90. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
    91. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
    92. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
    93. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
    94. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
    95. Roser,Bruce J.; Kampinga,Jaap; Colaco,Camilo; Blair,Julian, Solid dose delivery vehicle and methods of making same.
    96. Hansen, Henrik Egesborg; Buch-Rasmussen, Thomas; Sabra, Mads Christian, Solid dose micro implant.
    97. Bennett, David B.; Brewer, Thomas K.; Platz, Robert M.; Snyder, Herman, Spray drying process control of drying kinetics.
    98. Bennett, David B; Brewer, Thomas K; Platz, Robert M; Snyder, Herman, Spray drying process control of drying kinetics.
    99. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis; Tarara, Thomas E.; Kabalnov, Alexey, Stabilized preparations for use in metered dose inhalers.
    100. Schutt, Ernest G.; Tarara, Thomas E.; Dellamary, Luis A.; Kabalnov, Alexey; Weers, Jeffry G., Stabilized preparations for use in nebulizers.
    101. Harel, Moti; Tang, Qiong; Rice, Trisha; Jennings, Kimberly; Carpenter, Brian; Drewes, Roger; Raditsis, Elizabeth; Scarbrough, January, Stabilizing composition for biological materials.
    102. Harel, Moti; Tang, Qiong; Rice, Trisha; Jennings, Kimberly; Carpenter, Brian; Drewes, Roger; Raditsis, Elizabeth; Scarbrough, January, Stabilizing composition for biological materials.
    103. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
    104. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
    105. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
    106. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
    107. Prestrelski, Steven J.; Scott, Nancy, Stable formulations for parenteral injection of small molecule drugs.
    108. Prestrelski, Steven; Fang, Wei-Jie; Carpenter, John F.; Kinzell, John, Stable glucagon formulations for the treatment of hypoglycemia.
    109. Dellamary, Luis A.; Reiss, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery.
    110. Dellamary, Luis A.; Riess, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
    111. Dellamary, Luis A; Riess, Jean; Schutt, Ernest G; Weers, Jeffry G; Tarara, Thomas E, Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
    112. Kampinga, Jaap, Stable particle in liquid formulations.
    113. Schultz, Thomas; Clark, Bradley A.; Falzone, Angela, Steroid hormone products and methods for preparing them.
    114. Gordon, Marc S.; Clark, Andrew; Brewer, Thomas K., Systems and processes for spray drying hydrophobic and hydrophilic components.
    115. Glenn, Gregory M.; Alving, Carl R., Transcutaneous immunization without heterologous adjuvant.
    116. Eppstein, Jonathan; McRae, Stuart, Transdermal integrated actuator device, methods of making and using same.
    117. Eppstein, Jonathan; McRae, Stuart, Transdermal integrated actuator device, methods of making and using same.
    118. Eppstein, Jonathan; McRae, Stuart, Transdermal integrated actuator device, methods of making and using same.
    119. McRae, Stuart; Bowerman, Wendy E.; Braun, Stephen Wilson; Spiehl, Regina; Messier, Bernadette; Farquhar, David; Henkel, Erin Koch; O'Leary, Jeremiah Peter; Fisher, Mark James; Kascak, Uros; Lantz, Loren J.; Novakovic, Zoran; Eppstein, Jonathan, Transdermal porator and patch system and method for using same.
    120. Messier, Bernadette; Novakovic, Zoran; O'Leary, Jeremiah Peter; Spiehl, Regina; Bowerman, Wendy E.; Braun, Stephen Wilson; Eppstein, Jonathan; Farquhar, David; Fisher, Mark James; Kascak, Uros; Henkel, Erin Koch; Lantz, Loren J.; McRae, Stuart, Transdermal porator and patch system and method for using same.
    121. Messier, Bernadette; Novakovic, Zoran; O'Leary, Jeremiah Peter; Spiehl, Regina; Bowerman, Wendy E.; Braun, Stephen Wilson; Eppstein, Jonathan; Farquhar, David; Fisher, Mark James; Kascak, Uros; Henkel, Erin Koch; Lantz, Loren J.; McRae, Stuart, Transdermal porator and patch system and method for using same.
    122. Carpentier, Alain F.; Carpentier, Sophie; Cunanan, Crystal M.; Quintero, Lillian J.; Helmus, Michael N.; Loshbaugh, Christine; Sarner, H. Chris, Treating biological tissues to mitigate post-implantation calcification.
    123. Christopher Vincent Doidge AU; Adrian Lee AU, Treatment of H. pylori associated gastroduodenal disease.
    124. Carpentier, Sophie M.; Carpentier, Alain F., Treatment of bioprosthetic tissues to mitigate post implantation calcification.
    125. Glenn, Gregory M.; Alving, Carl R., Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response.
    126. Glenn,Gregory M.; Alving,Carl R., Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant.
    127. Glenn, Gregory M.; Cassels, Frederick J., Vaccine for transcutaneous immunization.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로